← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-04 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-723 | 70004-723-09 | Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-6114 | 73271-6114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:926 | 926 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6006 | 71286-6006-1 | Lidocaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-6 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:926 | 926 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-2 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5156 | 26436-5156-1 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9017 | 83826-9017-8 | Moxifloxacin Hydrochloride; Ketorolac Tromethamine; Prednisolone Sodium Phosphate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2321 | 72934-2321-2 | Niacinamide; Dapsone | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1571 | 72934-1571-2 | Niacinamide; Spironolactone | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:926 | 926 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5233 | 26436-5233-3 | Nystatin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:926 | 926 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:927 | 927 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6521 | 72934-6521-2 | Mecorix | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:927 | 927 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-23 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:927 | 927 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:927 | 927 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:927 | 927 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1114 | 73271-1114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:927 | 927 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-1 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:927 | 927 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:927 | 927 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-5 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:927 | 927 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:927 | 927 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-1 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:927 | 927 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-310 | 70092-310-46 | Methohexital Sodium | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:927 | 927 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9016 | 83826-9016-8 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:927 | 927 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2362 | 72934-2362-2 | Niacinamide; Fluocinolone Acetonide | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:927 | 927 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2577 | 72934-2577-2 | Niacinamide; Tazarotene | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:927 | 927 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ondansetron Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:927 | 927 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-030 | 69852-030-50 | Oxytocin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:928 | 928 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-6087 | 79559-6087-1 | S-TT087 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:928 | 928 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-09 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:928 | 928 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:928 | 928 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:928 | 928 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-7114 | 73271-7114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:928 | 928 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0000 | 81483-0000-0 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:928 | 928 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:928 | 928 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-4 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:928 | 928 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-63 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:928 | 928 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-6 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:928 | 928 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5239 | 26436-5239-3 | Methylcobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:928 | 928 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9014 | 83826-9014-5 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:928 | 928 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1400 | 72934-1400-2 | Niacinamide; Ivermectin; Metronidazole | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:928 | 928 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2324 | 72627-2324-7 | Niacinamide; Tirzepatide | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:928 | 928 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:928 | 928 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-519 | 83298-519-10 | Oxytocin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:929 | 929 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5526 | 26436-5526-0 | Combo Drops | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-202 | 70004-202-16 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5096 | 26436-5096-2 | Lidocaine Hydrochloride Anhydrous | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:929 | 929 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-4114 | 73271-4114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0001 | 81483-0001-0 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:929 | 929 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-16 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-62 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-1 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1223 | 70657-1223-3 | Methylcobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:929 | 929 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1399 | 72934-1399-2 | Niacinamide; Ivermectin; Metronidazole; Brimonidine Tartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2324 | 72627-2324-8 | Niacinamide; Tirzepatide | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5000 | 71266-5000-1 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:929 | 929 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-517 | 83298-517-10 | Oxytocin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:930 | 930 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3715 | 72682-3715-1 | Estradiol 15mg | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-30 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-725 | 70004-725-09 | Lidocaine Hydrochloride Anhydrous | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-4025 | 73271-4025-1 | Lidocaine Hydrochloride; Triamcinolone Acetonide | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-3114 | 73271-3114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0002 | 81483-0002-0 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8088 | 71285-8088-1 | Lidocaine Hydrochloride Anhydrous | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-01 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-59 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-2 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1013 | 70657-1013-3 | Methylcobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:930 | 930 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2391 | 72934-2391-2 | Niacinamide; Lactic Acid | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2546 | 72934-2546-2 | Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:930 | 930 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6043 | 71285-6043-1 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:930 | 930 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:931 | 931 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-725 | 70004-725-05 | Lidocaine Hydrochloride Anhydrous | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1235 | 5446-1235-01 | Lidocaine; Benzocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0863 | 5446-0863-01 | Lidocaine; Racepinephrine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:931 | 931 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8089 | 71285-8089-1 | Lidocaine Hydrochloride Anhydrous | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-02 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-16 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1337 | 61141-1337-1 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:931 | 931 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5416 | 72934-5416-2 | Mupirocin; Metronidazole | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1341 | 72934-1341-2 | Niacinamide; Levocetirizine Dihydrochloride; Imiquimod | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2564 | 72934-2564-4 | Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:931 | 931 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:931 | 931 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:932 | 932 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0405 | 71285-0405-1 | Trophamine 3% / Dextrose 10% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-16 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-725 | 70004-725-12 | Lidocaine Hydrochloride Anhydrous | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3100 | 72627-3100-1 | Lidocaine; Benzocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1268 | 5446-1268-01 | Lidocaine; Racepinephrine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-949 | 69374-949-05 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5480 | 26436-5480-1 | Lidocaine Hydrochloride Anhydrous | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-132 | 73177-132-16 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-522 | 70092-522-35 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5020 | 70214-5020-1 | Midazolam | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:932 | 932 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0407 | 71285-0407-1 | N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1311 | 72934-1311-2 | Niacinamide; Spironolactone | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:932 | 932 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2564 | 72934-2564-2 | Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:932 | 932 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:932 | 932 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:933 | 933 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-033 | 71506-033-58 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:933 | 933 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-06 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:933 | 933 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8088 | 71285-8088-1 | Lidocaine Hydrochloride Anhydrous | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:933 | 933 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3101 | 72627-3101-1 | Lidocaine; Benzocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:933 | 933 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0607 | 5446-0607-01 | Lidocaine; Racepinephrine; Tetracaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:933 | 933 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-985 | 69374-985-05 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:933 | 933 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:933 | 933 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:933 | 933 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:933 | 933 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:933 | 933 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5194 | 26436-5194-3 | Methylcobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:933 | 933 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6026 | 26436-6026-1 | Nadide | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:933 | 933 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2318 | 72934-2318-2 | Niacinamide; Tazarotene | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:933 | 933 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1564 | 72934-1564-2 | Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:933 | 933 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6044 | 71285-6044-1 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:933 | 933 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-018 | 72055-018-01 | Oxytocin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:934 | 934 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-009 | 73198-009-10 | NB-243 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:934 | 934 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-203 | 70004-203-32 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:934 | 934 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8089 | 71285-8089-1 | Lidocaine Hydrochloride Anhydrous | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:934 | 934 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Bupivacaine; Hyaluronidase | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:934 | 934 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:934 | 934 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:934 | 934 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:934 | 934 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-523 | 70092-523-50 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:934 | 934 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:934 | 934 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:934 | 934 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5015 | 26436-5015-3 | Methylcobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:934 | 934 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5558 | 26436-5558-5 | Nadide | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:934 | 934 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Niacinamide; Tretinoin | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:934 | 934 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2561 | 72934-2561-2 | Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:934 | 934 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8069 | 71285-8069-1 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:934 | 934 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:935 | 935 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6515 | 72934-6515-2 | Mokura | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:935 | 935 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-229 | 70004-229-40 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:935 | 935 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:935 | 935 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1543 | 5446-1543-01 | Lidocaine; Hyaluronidase; Bupivacaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:935 | 935 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3102 | 72627-3102-1 | Lidocaine; Tetracaine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:935 | 935 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:935 | 935 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:935 | 935 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-04 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:935 | 935 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1021 | 73013-1021-1 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:935 | 935 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:935 | 935 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5055 | 26436-5055-3 | Methylcobalamin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:935 | 935 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-141 | 73702-141-32 | Naloxone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:935 | 935 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2304 | 72934-2304-2 | Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:935 | 935 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1545 | 72934-1545-2 | Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:935 | 935 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-517 | 83298-517-10 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:935 | 935 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-028 | 71506-028-59 | Oxytocin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:936 | 936 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-103 | 69761-103-01 | Testosterone | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:936 | 936 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-229 | 70004-229-32 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:936 | 936 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:936 | 936 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1548 | 5446-1548-01 | Lidocaine; Hyaluronidase; Bupivacaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:936 | 936 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:936 | 936 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:936 | 936 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6591 | 71300-6591-1 | Lidocaine Hydrochloride; Bupivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:936 | 936 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-05 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:936 | 936 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1022 | 73013-1022-1 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:936 | 936 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:936 | 936 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:936 | 936 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5556 | 26436-5556-1 | Naltrexone | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:936 | 936 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2306 | 72934-2306-2 | Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:936 | 936 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2566 | 72934-2566-2 | Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:936 | 936 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-012 | 68985-012-93 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:936 | 936 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-012 | 68985-012-93 | Oxytocin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:937 | 937 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5343 | 26436-5343-1 | Estriol | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:937 | 937 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:937 | 937 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:937 | 937 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1480 | 5446-1480-01 | Lidocaine; Hyaluronidase; Racepinephrine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:937 | 937 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine; Benzocaine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:937 | 937 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:937 | 937 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Bupivacaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:937 | 937 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-17 | Morphine Sulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:937 | 937 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-022 | 71449-022-32 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:937 | 937 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:937 | 937 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:937 | 937 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0724 | 26436-0724-9 | Naltrexone | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:937 | 937 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2309 | 72934-2309-2 | Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:937 | 937 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2569 | 72934-2569-2 | Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:937 | 937 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-018 | 72055-018-01 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:937 | 937 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5007 | 26436-5007-3 | Panthenol | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:938 | 938 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2467 | 72907-2467-1 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:938 | 938 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:938 | 938 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Glutamine; Ornithine; Lysine Hydrochloride; Arginine; Citrulline | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:938 | 938 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1256 | 5446-1256-01 | Lidocaine; Oxymetazoline Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:938 | 938 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine; Benzocaine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:938 | 938 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:938 | 938 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6290 | 71266-6290-1 | Lidocaine Hydrochloride; Epinephrine Bitartrate; Tetracaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:938 | 938 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate Anhydrous | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:938 | 938 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-103 | 70004-103-16 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 |